AbbVie Non-GAAP EPS of $2.65 misses by $0.01, revenue of $14.46B beats by $430M

by
Contributor since / Followers

4 months ago

AbbVie press release (NYSE:ABBV): Q2 Non-GAAP EPS of $2.65 misses by $0.01.
Revenue of $14.46B (+4.3% Y/Y) beats by $430M.
Raises 2024 Adjusted Diluted EPS Guidance Range from $10.61 – $10.81 to $10.71 – $10.91 vs. $11.14 consensus, which Includes an Unfavorable Impact of $0.60 Per Share Related to Acquired IPR&D and Milestones Expense Incurred Year-To-Date Through the Second Quarter 2024.

Tags: ABBV